Certain ‘repugnant’ transactions, such as the sale of organs, are prohibited on moral grounds, despite substantial potential efficiency gains. This column uses a survey-based experiment to explore public perceptions of the morality–efficiency trade-off in the context of the US kidney procurement system. Respondents are found to accept higher levels of repugnance for higher levels of efficiency. These results suggest room for efficiency concerns alongside moral and ethical considerations.